Published in Biochem Soc Trans on May 01, 1997
Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev (2005) 14.71
Characterization of a murine model of melioidosis: comparison of different strains of mice. Infect Immun (1999) 1.75
Inflammasome-dependent pyroptosis and IL-18 protect against Burkholderia pseudomallei lung infection while IL-1β is deleterious. PLoS Pathog (2011) 1.68
Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomallei. Infect Immun (2000) 1.56
Development of vaccines against burkholderia pseudomallei. Front Microbiol (2011) 1.10
Caspase-1-dependent and -independent cell death pathways in Burkholderia pseudomallei infection of macrophages. PLoS Pathog (2014) 0.91
Prophylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosis. PLoS One (2012) 0.89
Cultivation of anaerobic intestinal bacteria. J Pathol Bacteriol (1967) 8.83
Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis (1989) 8.24
Studies on the intestinal flora. I. The bacterial flora of the gastrointestinal tract in healthy and achlorhydric persons. Gastroenterology (1969) 5.43
Bacteria and aetiology of cancer of large bowel. Lancet (1971) 5.16
Halving of mortality of severe melioidosis by ceftazidime. Lancet (1989) 4.70
Bacteria and the aetiology of cancer of the large bowel. Gut (1969) 3.57
A T cell-independent mechanism of macrophage activation by interferon-gamma. J Immunol (1987) 3.55
Imported melioidosis in England and Wales. Lancet (1999) 3.42
Detection of Brucella melitensis and Brucella abortus by DNA amplification. J Trop Med Hyg (1992) 3.32
The epidemiology of melioidosis in Ubon Ratchatani, northeast Thailand. Int J Epidemiol (1994) 3.23
Degradation of bile salts by human intestinal bacteria. Gut (1968) 3.15
Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol (2001) 2.70
Relapse in melioidosis: incidence and risk factors. J Infect Dis (1993) 2.61
Regulation of macrophage Ia expression in mice with severe combined immunodeficiency: induction of Ia expression by a T cell-independent mechanism. J Immunol (1986) 2.51
Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J Immunol (1981) 2.50
Obligatory role of gamma interferon for host survival in a murine model of infection with Burkholderia pseudomallei. Infect Immun (1999) 2.41
Faecal bile-acids and clostridia in patients with cancer of the large bowel. Lancet (1975) 2.40
The use of selective media for the isolation of Pseudomonas pseudomallei in clinical practice. J Med Microbiol (1990) 2.39
Environmental factors and cancer of the colon and breast. Br J Cancer (1973) 2.36
Is there an acute-phase response in steady-state sickle cell disease? Lancet (1993) 2.35
Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc Natl Acad Sci U S A (1981) 2.31
Characterization of auxotrophic mutants of Mycobacterium tuberculosis and their potential as vaccine candidates. Infect Immun (2001) 2.21
Serology and carriage of Pseudomonas pseudomallei: a prospective study in 1000 hospitalized children in northeast Thailand. J Infect Dis (1993) 2.20
Cytokine enhancement of complement-dependent phagocytosis by macrophages: synergy of tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor for phagocytosis of Cryptococcus neoformans. Eur J Immunol (1992) 2.16
Response of toxigenic Vibrio cholerae 01 to physico-chemical stresses in aquatic environments. J Hyg (Lond) (1984) 2.12
Biochemical characteristics of clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol (1996) 2.11
Effects of Burkholderia pseudomallei and other Burkholderia species on eukaryotic cells in tissue culture. Microbios (1998) 2.11
Breath-hydrogen test for small-intestinal bacterial colonisation. Lancet (1976) 2.09
The deconjugation of bile salts by human intestinal bacteria. Lancet (1966) 2.06
The aquatic flora and fauna as reservoirs of Vibrio cholerae: a review. J Diarrhoeal Dis Res (1994) 2.04
Antibacterial antibodies in rectal and colonic mucosa in ulcerative colitis. Lancet (1971) 1.88
Prognostic significance of quantitative bacteremia in septicemic melioidosis. Clin Infect Dis (1995) 1.76
Intestinal bacteria and the hydrolysis of glycosidic bonds. J Med Microbiol (1971) 1.73
Isolation of Pseudomonas pseudomallei from soil in north-eastern Thailand. Trans R Soc Trop Med Hyg (1995) 1.73
The non-sporing anaerobic bacteria in human faeces. J Med Microbiol (1974) 1.68
Degradation of bile salts by human intestinal bacteria. Gut (1969) 1.66
Revised guidelines for control of MRSA in hospitals: finding the most useful point. J Hosp Infect (1999) 1.64
Long-term persistence of toxigenic Vibrio cholerae 01 in the mucilaginous sheath of a blue-green alga, Anabaena variabilis. J Trop Med Hyg (1990) 1.62
Clinical and laboratory studies of malaria and melioidosis. Trans R Soc Trop Med Hyg (1988) 1.59
Clostridia isolated from faeces. J Med Microbiol (1976) 1.58
Ceftazidime vs. amoxicillin/clavulanate in the treatment of severe melioidosis. Clin Infect Dis (1994) 1.57
A prospective comparison of co-amoxiclav and the combination of chloramphenicol, doxycycline, and co-trimoxazole for the oral maintenance treatment of melioidosis. Trans R Soc Trop Med Hyg (1996) 1.55
Immune responses to Cryptosporidium muris and Cryptosporidium parvum in adult immunocompetent or immunocompromised (nude and SCID) mice. Infect Immun (1992) 1.55
Water supply and nutritional status in rural northern Nigeria. Trans R Soc Trop Med Hyg (1978) 1.54
Development of signature-tagged mutagenesis in Burkholderia pseudomallei to identify genes important in survival and pathogenesis. Infect Immun (2006) 1.54
Encapsulation of Cryptococcus neoformans impairs antigen-specific T-cell responses. Infect Immun (1991) 1.54
Melioidosis in Bangladesh: a case report. Trans R Soc Trop Med Hyg (1988) 1.53
Site-directed mutagenesis of the 19-kilodalton lipoprotein antigen reveals No essential role for the protein in the growth and virulence of Mycobacterium intracellulare. Infect Immun (1998) 1.53
Studies on the intestinal flora. II. Bacterial flora of the small intestine in patients with gastrointestinal disorders. Gut (1969) 1.53
Ribotyping and DNA macrorestriction analysis of isolates of Burkholderia pseudomallei from cases of melioidosis in Malaysia. Trans R Soc Trop Med Hyg (1997) 1.52
Cholera epidemiology in developed and developing countries: new thoughts on transmission, seasonality, and control. Lancet (1985) 1.51
Electrically-heated inoculating loop. J Clin Pathol (1968) 1.51
Attachment of toxigenic Vibrio cholerae 01 to various freshwater plants and survival with a filamentous green alga, Rhizoclonium fontanum. J Trop Med Hyg (1989) 1.49
Pathology of Listeria infection in murine severe combined immunodeficiency. A study by immunohistochemistry and electron microscopy. Lab Invest (1988) 1.45
Homogeneity of lipopolysaccharide antigens in Pseudomonas pseudomallei. J Infect (1992) 1.45
Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form. Infect Immun (1995) 1.45
Mechanisms of granuloma formation in murine Mycobacterium avium infection: the contribution of CD4+ T cells. Int Immunol (1996) 1.44
Burkholderia pseudomallei and Indian plague-like illness. Lancet (1995) 1.44
Control of MRSA. J Hosp Infect (2000) 1.42
Species of alpha-hemolytic streptococci possessing a C-polysaccharide phosphorylcholine-containing antigen. Infect Immun (1993) 1.42
Bacterial colonisation of jejunal mucosa in acute tropical sprue. Lancet (1975) 1.41
Effect of feeding on infants' faecal flora. Arch Dis Child (1982) 1.41
The effect of a chemically defined diet on the faecal flora and faecal steroid concentration. Gut (1973) 1.40
Diploma in Hospital Infection Control (Dip HIC) J Hosp Infect (1997) 1.39
Passive protection of diabetic rats with antisera specific for the polysaccharide portion of the lipopolysaccharide isolated from Pseudomonas pseudomallei. Can J Infect Dis (1994) 1.38
Ribotype differences between clinical and environmental isolates of Burkholderia pseudomallei. J Med Microbiol (1997) 1.38
Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis. J Clin Microbiol (1993) 1.37
Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase. Antimicrob Agents Chemother (1991) 1.37
Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect Immun (1995) 1.32
Influence of diets high and low in animal fat on bowel habit, gastrointestinal transit time, fecal microflora, bile acid, and fat excretion. J Clin Invest (1978) 1.32
Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis (1993) 1.30
Leishmania donovani infection in scid mice: lack of tissue response and in vivo macrophage activation correlates with failure to trigger natural killer cell-derived gamma interferon production in vitro. Infect Immun (1992) 1.29
The aquatic environment as a reservoir of Vibrio cholerae: a review. J Diarrhoeal Dis Res (1993) 1.28
Association of Vibrio cholerae with fresh water amoebae. J Med Microbiol (1992) 1.26
Comparison of serum amyloid A protein and C-reactive protein concentrations in cancer and non-malignant disease. J Clin Pathol (1983) 1.25
The effect of a strict vegetarian diet on the faecal flora and faecal steroid concentration. J Pathol (1971) 1.24
Influence of morbidity on serum retinol of children in a community-based study in northern Ghana. Am J Clin Nutr (1993) 1.23
Probable role of blue-green algae in maintaining endemicity and seasonality of cholera in Bangladesh: a hypothesis. J Diarrhoeal Dis Res (1994) 1.20
The biology of the SCID mutation. Immunol Today (1989) 1.19
The influence of a diet rich in wheat fibre on the human faecal flora. J Med Microbiol (1976) 1.18
Production of matrix metalloproteinases in response to mycobacterial infection. Infect Immun (2001) 1.17
Acute-phase protein response is impaired in severely malnourished children. Clin Sci (Lond) (1993) 1.17
Physiological mechanism and pathogenesis of weanling diarrhea. Am J Clin Nutr (1972) 1.16
Measurement of acute phase proteins for assessing severity of Plasmodium falciparum malaria. J Clin Pathol (1991) 1.14
Pseudomonas pseudomallei liver abscesses: a clinical, laboratory, and ultrasonographic study. Clin Infect Dis (1992) 1.14
Molecular phylogeny of Burkholderia pseudomallei. Acta Trop (2000) 1.14
Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol (1994) 1.13
Inactivation of mycobacteriophage D29 using ferrous ammonium sulphate as a tool for the detection of viable Mycobacterium smegmatis and M. tuberculosis. Res Microbiol (1998) 1.13
Immunity to Cryptosporidium muris infection in mice is expressed through gut CD4+ intraepithelial lymphocytes. Infect Immun (1996) 1.11
Detection of Pseudomonas pseudomallei antigen in urine for the diagnosis of melioidosis. Am J Trop Med Hyg (1994) 1.10
Some factors associated with geographical variations in the intestinal microflora. Soc Appl Bacteriol Symp Ser (1974) 1.10
Pseudomonas pseudomallei: danger in the paddy fields. Trans R Soc Trop Med Hyg (1991) 1.10
Faecal steroids and bacteria and large bowel cancer in Hong Kong by socio-economic groups. Br J Cancer (1976) 1.10
Stability of strain genotypes of Burkholderia pseudomallei from patients with single and recurrent episodes of melioidosis. Trop Med Int Health (1998) 1.08